PDIP3_HUMAN - dbPTM
PDIP3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PDIP3_HUMAN
UniProt AC Q9BY77
Protein Name Polymerase delta-interacting protein 3
Gene Name POLDIP3
Organism Homo sapiens (Human).
Sequence Length 421
Subcellular Localization Nucleus. Nucleus speckle. Cytoplasm. Nucleocytoplasmic shuttling protein.
Protein Description Is involved in regulation of translation. Is preferentially associated with CBC-bound spliced mRNA-protein complexes during the pioneer round of mRNA translation. Contributes to enhanced translational efficiency of spliced over nonspliced mRNAs. Recruits activated ribosomal protein S6 kinase beta-1 I/RPS6KB1 to newly synthesized mRNA. Involved in nuclear mRNA export; probably mediated by assoociation with the TREX complex..
Protein Sequence MADISLDELIRKRGAAAKGRLNARPGVGGVRSRVGIQQGLLSQSTRTATFQQRFDARQKIGLSDARLKLGVKDAREKLLQKDARFRIKGKVQDAREMLNSRKQQTTVPQKPRQVADAREKISLKRSSPAAFINPPIGTVTPALKLTKTIQVPQQKAMAPLHPHPAGMRINVVNNHQAKQNLYDLDEDDDGIASVPTKQMKFAASGGFLHHMAGLSSSKLSMSKALPLTKVVQNDAYTAPALPSSIRTKALTNMSRTLVNKEEPPKELPAAEPVLSPLEGTKMTVNNLHPRVTEEDIVELFCVCGALKRARLVHPGVAEVVFVKKDDAITAYKKYNNRCLDGQPMKCNLHMNGNVITSDQPILLRLSDSPSMKKESELPRRVNSASSSNPPAEVDPDTILKALFKSSGASVTTQPTEFKIKL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MADISLDEL
------CCCCCHHHH
23.8922223895
5Phosphorylation---MADISLDELIRK
---CCCCCHHHHHHH
30.2525159151
11MethylationISLDELIRKRGAAAK
CCHHHHHHHHCHHHH
34.93115917017
33MethylationGVGGVRSRVGIQQGL
CCCCHHHHHHHCCCC
21.8124129315
42PhosphorylationGIQQGLLSQSTRTAT
HHCCCCCCCCCCCCH
27.4217525332
44PhosphorylationQQGLLSQSTRTATFQ
CCCCCCCCCCCCHHH
19.2423911959
45PhosphorylationQGLLSQSTRTATFQQ
CCCCCCCCCCCHHHH
25.1326074081
63PhosphorylationARQKIGLSDARLKLG
HHHHHCCCHHHHHHC
24.8220068231
66MethylationKIGLSDARLKLGVKD
HHCCCHHHHHHCCHH
37.03115917021
72AcetylationARLKLGVKDAREKLL
HHHHHCCHHHHHHHH
43.8225953088
88MethylationKDARFRIKGKVQDAR
CCCHHHHCCHHHHHH
48.71116253695
102UbiquitinationREMLNSRKQQTTVPQ
HHHHHCCCCCCCCCC
46.72-
102MethylationREMLNSRKQQTTVPQ
HHHHHCCCCCCCCCC
46.72116253689
105PhosphorylationLNSRKQQTTVPQKPR
HHCCCCCCCCCCCHH
27.5420363803
106PhosphorylationNSRKQQTTVPQKPRQ
HCCCCCCCCCCCHHH
26.3320363803
110UbiquitinationQQTTVPQKPRQVADA
CCCCCCCCHHHHHHH
35.78-
122PhosphorylationADAREKISLKRSSPA
HHHHHHHCCCCCCCC
38.6229449344
126PhosphorylationEKISLKRSSPAAFIN
HHHCCCCCCCCCCCC
38.8029255136
127PhosphorylationKISLKRSSPAAFINP
HHCCCCCCCCCCCCC
23.6929255136
138 (in isoform 2)Phosphorylation-23.1725159151
138PhosphorylationFINPPIGTVTPALKL
CCCCCCCCCCHHHHC
23.1725159151
140 (in isoform 2)Phosphorylation-11.5925159151
140PhosphorylationNPPIGTVTPALKLTK
CCCCCCCCHHHHCCC
11.5923927012
144AcetylationGTVTPALKLTKTIQV
CCCCHHHHCCCEECC
57.1025953088
144UbiquitinationGTVTPALKLTKTIQV
CCCCHHHHCCCEECC
57.10-
146PhosphorylationVTPALKLTKTIQVPQ
CCHHHHCCCEECCCC
25.2623312004
147 (in isoform 2)Ubiquitination-54.81-
147UbiquitinationTPALKLTKTIQVPQQ
CHHHHCCCEECCCCC
54.81-
148 (in isoform 2)Phosphorylation-16.0628796482
153 (in isoform 2)Phosphorylation-59.5628796482
155UbiquitinationTIQVPQQKAMAPLHP
EECCCCCCCCCCCCC
34.58-
168 (in isoform 2)Ubiquitination-19.1921890473
171 (in isoform 2)Ubiquitination-4.54-
178UbiquitinationVVNNHQAKQNLYDLD
EECCCHHHHCCCCCC
32.90-
182PhosphorylationHQAKQNLYDLDEDDD
CHHHHCCCCCCCCCC
23.2428796482
193PhosphorylationEDDDGIASVPTKQMK
CCCCCCCCCCHHHEE
27.0624532841
197UbiquitinationGIASVPTKQMKFAAS
CCCCCCHHHEEEHHC
42.1821906983
200 (in isoform 2)Ubiquitination-29.3821890473
200UbiquitinationSVPTKQMKFAASGGF
CCCHHHEEEHHCCCH
29.3821890473
200SumoylationSVPTKQMKFAASGGF
CCCHHHEEEHHCCCH
29.3828112733
204PhosphorylationKQMKFAASGGFLHHM
HHEEEHHCCCHHHHH
35.7028450419
214 (in isoform 1)Ubiquitination-3.0521890473
215PhosphorylationLHHMAGLSSSKLSMS
HHHHCCCCCCCCCHH
31.4825159151
216PhosphorylationHHMAGLSSSKLSMSK
HHHCCCCCCCCCHHH
36.2129396449
217PhosphorylationHMAGLSSSKLSMSKA
HHCCCCCCCCCHHHH
33.9529396449
218AcetylationMAGLSSSKLSMSKAL
HCCCCCCCCCHHHHC
46.6725953088
223SumoylationSSKLSMSKALPLTKV
CCCCCHHHHCCCCEE
45.3528112733
223UbiquitinationSSKLSMSKALPLTKV
CCCCCHHHHCCCCEE
45.35-
229UbiquitinationSKALPLTKVVQNDAY
HHHCCCCEEECCCCC
48.3621890473
236PhosphorylationKVVQNDAYTAPALPS
EEECCCCCCCCCCCH
13.2921945579
237PhosphorylationVVQNDAYTAPALPSS
EECCCCCCCCCCCHH
28.0821945579
243PhosphorylationYTAPALPSSIRTKAL
CCCCCCCHHHHHHHH
38.9721945579
244PhosphorylationTAPALPSSIRTKALT
CCCCCCHHHHHHHHH
17.7221945579
247PhosphorylationALPSSIRTKALTNMS
CCCHHHHHHHHHHHC
20.9926074081
248UbiquitinationLPSSIRTKALTNMSR
CCHHHHHHHHHHHCC
31.39-
248SumoylationLPSSIRTKALTNMSR
CCHHHHHHHHHHHCC
31.3928112733
251PhosphorylationSIRTKALTNMSRTLV
HHHHHHHHHHCCCCC
33.4629978859
254PhosphorylationTKALTNMSRTLVNKE
HHHHHHHCCCCCCCC
24.9628985074
256PhosphorylationALTNMSRTLVNKEEP
HHHHHCCCCCCCCCC
27.9628387310
260AcetylationMSRTLVNKEEPPKEL
HCCCCCCCCCCCCCC
56.8526051181
260UbiquitinationMSRTLVNKEEPPKEL
HCCCCCCCCCCCCCC
56.85-
265UbiquitinationVNKEEPPKELPAAEP
CCCCCCCCCCCCCCC
80.66-
265AcetylationVNKEEPPKELPAAEP
CCCCCCCCCCCCCCC
80.6626051181
275PhosphorylationPAAEPVLSPLEGTKM
CCCCCCCCCCCCCCC
27.8929255136
280PhosphorylationVLSPLEGTKMTVNNL
CCCCCCCCCCCCCCC
14.3129255136
303 (in isoform 2)Ubiquitination-2.5121890473
307AcetylationFCVCGALKRARLVHP
HHHHHHHHHHCCCCC
43.4020167786
323AcetylationVAEVVFVKKDDAITA
EEEEEEEECCCHHHH
38.7326051181
329PhosphorylationVKKDDAITAYKKYNN
EECCCHHHHHHHHCC
26.17-
332UbiquitinationDDAITAYKKYNNRCL
CCHHHHHHHHCCEEC
46.442190698
349 (in isoform 1)Ubiquitination-8.1521890473
366PhosphorylationQPILLRLSDSPSMKK
CCEEEEECCCCCCCC
29.6124732914
368PhosphorylationILLRLSDSPSMKKES
EEEEECCCCCCCCHH
18.5923401153
370PhosphorylationLRLSDSPSMKKESEL
EEECCCCCCCCHHHC
47.3825159151
372UbiquitinationLSDSPSMKKESELPR
ECCCCCCCCHHHCCC
58.70-
372SumoylationLSDSPSMKKESELPR
ECCCCCCCCHHHCCC
58.7028112733
373UbiquitinationSDSPSMKKESELPRR
CCCCCCCCHHHCCCC
58.81-
375PhosphorylationSPSMKKESELPRRVN
CCCCCCHHHCCCCCC
54.0024732914
383PhosphorylationELPRRVNSASSSNPP
HCCCCCCCCCCCCCC
27.0329255136
385PhosphorylationPRRVNSASSSNPPAE
CCCCCCCCCCCCCCC
33.8329255136
386PhosphorylationRRVNSASSSNPPAEV
CCCCCCCCCCCCCCC
33.5729255136
387PhosphorylationRVNSASSSNPPAEVD
CCCCCCCCCCCCCCC
51.3529255136
400UbiquitinationVDPDTILKALFKSSG
CCHHHHHHHHHHCCC
38.91-
404UbiquitinationTILKALFKSSGASVT
HHHHHHHHCCCCCCC
44.56-
404MethylationTILKALFKSSGASVT
HHHHHHHHCCCCCCC
44.56115981161
405PhosphorylationILKALFKSSGASVTT
HHHHHHHCCCCCCCC
27.0322817900
406PhosphorylationLKALFKSSGASVTTQ
HHHHHHCCCCCCCCC
38.6822817900
409PhosphorylationLFKSSGASVTTQPTE
HHHCCCCCCCCCCCE
24.4223312004
411PhosphorylationKSSGASVTTQPTEFK
HCCCCCCCCCCCEEE
19.7423312004
412PhosphorylationSSGASVTTQPTEFKI
CCCCCCCCCCCEEEE
30.3223312004
418MethylationTTQPTEFKIKL----
CCCCCEEEECC----
32.4730795303
418UbiquitinationTTQPTEFKIKL----
CCCCCEEEECC----
32.47-
418SumoylationTTQPTEFKIKL----
CCCCCEEEECC----
32.4728112733

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
63SPhosphorylationKinaseCHEK1O14757
GPS
383SPhosphorylationKinaseKS6B1P23443
PhosphoELM
383SPhosphorylationKinaseP70-SUBFAMILY-GPS
385SPhosphorylationKinaseP70S6KP23443
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
383SPhosphorylation

15341740
385SPhosphorylation

15341740

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PDIP3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
KS6B1_HUMANRPS6KB1physical
15341740
NCBP1_HUMANNCBP1physical
18423201
IF4A3_HUMANEIF4A3physical
18423201
IF4G1_HUMANEIF4G1physical
25049393
LZTS2_HUMANLZTS2physical
25416956
K1C40_HUMANKRT40physical
25416956
IMA4_HUMANKPNA3physical
26186194
UBR1_HUMANUBR1physical
28514442
KLH22_HUMANKLHL22physical
28514442

Drug and Disease Associations
Kegg Disease
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PDIP3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-42, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-127, AND MASSSPECTROMETRY.
"SKAR is a specific target of S6 kinase 1 in cell growth control.";
Richardson C.J., Broenstrup M., Fingar D.C., Julich K., Ballif B.A.,Gygi S., Blenis J.;
Curr. Biol. 14:1540-1549(2004).
Cited for: INTERACTION WITH RPS6KB1, SUBCELLULAR LOCATION, PHOSPHORYLATION ATSER-127; SER-275; SER-383 AND SER-385, MUTAGENESIS OF SER-383 ANDSER-385, AND MASS SPECTROMETRY.
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-140, AND MASSSPECTROMETRY.

TOP